New CELEBREX® (celecoxib) Study Using Novel Endpoint, Published by The Lancet ... - PR Newswire (press release)

New CELEBREX® (celecoxib) Study Using Novel Endpoint, Published by The Lancet ... PR Newswire (press release) CELEBREX is currently approved in the US for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis in adults, juvenile rheumatoid ... and more »

Lady GaGa Tested Borderline Positive For Lupus: Dr. Robert Katz Explains - Vitals Spotlight

Lady GaGa Tested Borderline Positive For Lupus: Dr. Robert Katz Explains Vitals Spotlight (lupus.org) According to Vitals.com, Dr. Robert Katz is a rheumatologist with special expertise in Osteoarthritis, Rheumatoid Arthritis, and Systemic Lupus ... and more »

Pozen receives US$ 20 mn milestone payment from AstraZeneca for Vimovo - pharmabiz.com

TopNews United Kingdom (blog)

Pozen receives US$ 20 mn milestone payment from AstraZeneca for Vimovo pharmabiz.com Vimovo is approved for the relief of the signs and symptoms of osteoarthritis (OA), rheumatoid arthritis (RA) and ankylosing spondylitis (AS) and to ... FDA rejects AstraZeneca's Nexium/aspirin comboPharma Times all 69 news articles »

LAVALLEE v. ASTRUE - Leagle.com

LAVALLEE v. ASTRUE Leagle.com Id. On December 28, 2006, Dr. Mase diagnosed Lavallee with chronic changes consistent with osteoarthritis in her knees, including bony crepitus (the ...